---
category: news
title: "InterVenn Biosciences quintuples funding with $201M for AI-powered cancer tests"
excerpt: "Building on recent studies showcasing the success of its liquid biopsy tests, InterVenn has now raised $201 million to continue developing its glycoproteomics platform and more diagnostic assays. That marks an exponential increase in its lifetime funding,"
publishedDateTime: 2021-08-02T16:14:00Z
originalUrl: "https://www.fiercebiotech.com/medtech/intervenn-biosciences-quintuples-funding-201m-for-ai-powered-cancer-tests"
webUrl: "https://www.fiercebiotech.com/medtech/intervenn-biosciences-quintuples-funding-201m-for-ai-powered-cancer-tests"
type: article
quality: 33
heat: 33
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1627918080/GettyImages-1135384947_edited.jpeg/GettyImages-1135384947_edited.jpeg?U3_eN.1QSqR5FUnkTHWuopQoDT.8Vwv9"
    width: 800
    height: 534
    isCached: true

secured: "7iseCTrtbr/Q8uOOIc/6DknWvbg+HaNqWqG9oN8HhHeWKVr9Dj9+9Pqp3ozAORJHRfIdWWo9QnKwiyawJ1ys0LO+0pcDT732QFkCC/o96LVuoY/kaGJT8fWEOBVAYdqUicFOGh23TV/4PVSCMHug4PR5p/yDZQZNATFXT8q8NKiplIKIYresZBpNkwjLADALwA2gYbQr21K2p6aBQnhbsatkTFhZQMVC61l33/8T2ERuMerTSYujIOuPH0nUkBIJb27PTBendA62C2XyrKkGS/HeJn/jEWXM7uYXsitIMDyo0N1nsjKl5daOC9+tcIU0djwWXvsOSgPA4u6EcHO19NW+IexfE9B7z6dpv/jp1dQ=;EnnhLAB/cXowBoJB/3SUjA=="
---

